Unife has warned that EU member states are at risk of losing funding for vital rail schemes promised in the EU's Recovery and ...

With both the United States and the European Union changing their leadership the Wilson Center’s Global Europe Program and ...

In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...

The Bulgarian Parliament has recently adopted an Act to amend and supplement the Bulgarian Commercial Act[1] implementing the ...

The European Commission (EC) has adopted yesterday the fifth annual Work Programme under the European Defence Fund (EDF), ...

The European Commission (EC) has presented data regarding several criminal proceedings linked to the enforcement of EU law, with Bulgaria involved in seven of these cases. In the realm of crime ...

The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...

PRINCETON, N.J. - Bristol Myers Squibb (NYSE: BMY), a prominent pharmaceutical company with a market capitalization of nearly $120 billion and impressive gross profit margins of 76%, received a ...

AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...

The European Commission said on Friday that it has launched infringement procedures against Bulgaria for failing to fully ...

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the European Commission has asked the Committee for Medicinal Products for Human Use (CHMP) to consider two ...